22 May 2013
Keywords: merck, pasteur-merieux, venture, approved, eu, joint, between
Article | 11 April 1994
- A joint venture between Merck & Co and Pasteur-Merieux to develop
vaccines for diphtheria and tetanus has been approved by the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 April 1994
4 April 1994
21 May 2013
© 2013 thepharmaletter.com